Chapter 13A: Meaning of urine electrolytes


Measurement of the urinary electrolyte concentrations, osmolality, and pH play an important role in the diagnosis and management of a variety of disorders. This chapter will briefly review the meaning of these parameters and the settings in which they may be helpful (table 1). It is important to emphasize that there are no fixed normal values, since the kidney varies the rate of excretion to match net dietary intake and endogenous production. Thus, interpretation of a given test requires knowledge of the patient's clinical state. As an example, the urinary excretion of 125 meq of Na+ per day may be appropriate for a subject on a regular diet, but represents inappropriate renal Na+ wasting in a patient who is volume-depleted.

In addition to their clinical usefulness, these tests are simple to perform and are widely available. In most circumstances, a random urine specimen is sufficient, although a 24-h collection to determine the daily rate of solute excretion is occasionally indicated. When K+ depletion is due to extrarenal losses, for example, the urinary K+ excretion should fall below 25 meq/day. A random measurement, however, may be confusing in some patients. If the urine output is only 500 mL/day because of associated volume depletion, then the appropriate excretion of only 20 meq of K+ per day will be associated with an apparently high urine K+ concentration of 40 meq/L (20 meq/day  ÷  0.5 L/day  =  40 meq/L).


The kidney varies the rate of Na+ excretion to maintain the effective circulating volume, a response that is mediated by a variety of factors including the renin-angiotensin-aldosterone system and perhaps atrial natriuretic peptide and related peptides. (See "Chapter 8C: Regulation of renal Na+ excretion".) As a result, the urine Na+ concentration can be used as an estimate of the patient's volume status. In particular, a urine Na+ concentration below 20 meq/L is generally indicative of hypovolemia. This finding is especially useful in the differential diagnosis of both hyponatremia and acute renal failure. The two major causes of hyponatremia are effective volume depletion and the syndrome of inappropriate antidiuretic hormone secretion (SIADH). The urine Na+ concentration should be low in the former, but greater than 40 meq/L in the SIADH, which is characterized by water retention but normal Na+ handling (ie, equal to intake). (See "Evaluation of adults with hyponatremia".)

Similar considerations apply to acute renal failure which is most often due to volume depletion or acute tubular necrosis [1]. The urine Na+ concentration usually exceeds 40 meq/L in the latter, in part because of the associated tubular damage and a consequent inability to maximally reabsorb Na+ [1-3]. Measuring the fractional excretion of Na+ and the urine osmolality also can help to differentiate between these conditions (see below).

In normal subjects, urinary Na+ excretion roughly equals average dietary intake. Thus, measurement of urinary Na+ excretion (by obtaining a 24-h collection) can be used to check dietary compliance in patients with primary hypertension (formerly called "essential" hypertension). Restriction of Na+ intake is frequently an important component of the therapeutic regimen [4,5], and adequate adherence should result in the excretion of less than 100 meq/day.


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Aug 2014. | This topic last updated: Feb 13, 2008.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
  1. Rose BD. Pathophysiology of Renal Disease, 2nd ed, McGraw-Hill, New York 1987. p.82.
  2. Miller TR, Anderson RJ, Linas SL, et al. Urinary diagnostic indices in acute renal failure: a prospective study. Ann Intern Med 1978; 89:47.
  3. Espinel CH, Gregory AW. Differential diagnosis of acute renal failure. Clin Nephrol 1980; 13:73.
  4. Cutler JA, Follmann D, Allender PS. Randomized trials of sodium reduction: an overview. Am J Clin Nutr 1997; 65:643S.
  5. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure. I—An analysis of observational data among populations; III—Analysis of data of salt reduction. Br Med J 1991; 302:811,819.
  6. Wilcox CS, Guzman NJ, Mitch WE, et al. Na+, K+, and BP homeostasis in man during furosemide: effects of prazosin and captopril. Kidney Int 1987; 31:135.
  7. Bock HA, Stein JH. Diuretics and the control of extracellular fluid volume: role of counterregulation. Semin Nephrol 1988; 8:264.
  8. Maronde R Milgrom, M, Vlachakis, ND, Chan, L. Response of thiazide-induced hypokalemia to amiloride. J Am Med Assoc 1983; 249:237.
  9. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med 1992; 327:1141.
  10. Parks JH, Coe FL. A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int 1986; 30:85.
  11. Muldowney FP, Freaney R, Moloney MF. Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int 1982; 22:292.
  12. Besarab A, Brown RS, Rubin NT, et al. Reversible renal failure following bilateral renal artery occlusive disease: clinical features, pathology, and the role of surgical revascularization. J Am Med Assoc 1976; 235:2838.
  13. Danovitch GM, Bourgoignie JJ, Bricker NS. Reversibility of the "salt-losing" tendency of chronic renal failure. N Engl J Med 1977; 296:15.
  14. Steiner RW. Interpreting the fractional excretion of sodium. Am J Med 1984; 77:699.
  15. Planas M, Wachtel T, Frank H, Henderson LW. Characterization of acute renal failure in the burned patient. Arch Intern Med 1982; 142:2087.
  16. Diamond JR, Yoburn DC. Nonoliguric acute renal failure associated with a low fractional excretion of sodium. Ann Intern Med 1982; 96:597.
  17. Fang LS, Sirota RA, Ebert TH, Lichtenstein NS. Low fractional excretion of sodium with contrast media-induced acute renal failure. Arch Intern Med 1980; 140:531.
  18. Steinhäuslin F, Burnier M, Magnin JL, et al. Fractional excretion of trace lithium and uric acid in acute renal failure. J Am Soc Nephrol 1994; 4:1429.
  19. Sherman RA, Eisinger RP. The use (and misuse) of urinary sodium and chloride measurements. J Am Med Assoc 1982; 247:3121.
  20. Kamel KS, Ethier JH, Richardson RM, et al. Urine electrolytes and osmolality: when and how to use them. Am J Nephrol 1990; 10:89.
  21. Batlle DC, Hizon M, Cohen E, et al. The use of the urinary anion gap in the diagnosis of hyperchloremic metabolic acidosis. N Engl J Med 1988; 318:594.
  22. Goldstein MB, Bear R, Richardson RM, et al. The urine anion gap: a clinically useful index of ammonium excretion. Am J Med Sci 1986; 292:198.
  23. SQUIRES RD, HUTH EJ. Experimental potassium depletion in normal human subjects. I. Relation of ionic intakes to the renal conservation of potassium. J Clin Invest 1959; 38:1134.
  24. Talbott JH, Schwab RS. Recent advances in the biochemistry and therapeusis of potassium salts. N Engl J Med 1940; 222:585.
  25. Rabelink TJ, Koomans HA, Hené RJ, Dorhout Mees EJ. Early and late adjustment to potassium loading in humans. Kidney Int 1990; 38:942.